Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Tuberculosis and Trimethoprim-Sulfamethoxazole
Forgacs, Pierre, Wengenack, Nancy L. , Hall, Leslie, Zimmerman, Sarah K., Silverman, Mark L., Roberts, Glenn D.

Mayo Clinic

Antimicrobial Agents and Chemotherapy | June 30, 2009 | Volume: 53 | Issue: 11 | Pages: 4789-4793

10.1128/aac.01658-08 | PMID 19564358 Get It

ABSTRACTThe sulfonamides were the first drugs with antituberculous effects. Their use was abandoned and basically forgotten with the advent of streptomycin and isoniazid combination treatment. There is a widespread belief, apparently based on testing a single isolate on questionable media, thatMycobacterium tuberculosisis resistant to trimethoprim-sulfamethoxazole (TMP-SMX). We saw a complex immunocompromised patient with tuberculosis who was initially treated with TMP-SMX without antituberculous drugs and defervesced on this treatment. An isolate ofM. tuberculosisfrom this patient was found to be sensitive to TMP-SMX. We examined how frequentlyM. tuberculosisis sensitive to TMP-SMX. Isolates were tested for susceptibility to TMP-SMX on supplemented Middlebrook 7H10 plates. We found that 43 of 44 (98%) isolates ofM. tuberculosiswere susceptible to the combination of ≤1 μg/ml of TMP and 19 μg/ml of SMX (≤1/19 μg/ml). Thus, the vast majority of ourM. tuberculosisisolates were susceptible to TMP-SMX at an MIC similar to that forMycobacterium kansasii,Mycobacterium marinum, and sensitive rapidly growing mycobacteria, organisms successfully treated with TMP-SMX as part of the treatment regimen. It is possible that TMP-SMX may be useful in treating patients with multiple-drug-resistant and extended drug-resistant tuberculosis. We feel that a clinical trial looking at the effectiveness of TMP-SMX as an antituberculous drug is worthwhile.
Superior Immune Response to Protein-Conjugate versus Free Pneumococcal Polysaccharide Vaccine in Chronic Obstructive Pulmonary Disease
Nahm, Moon H. , Harnden, Sarah, Scanlon, Paul D., Woodruff, Prescott G. , Washko, George R. , Connett, John E. , Anthonisen, Nicholas R., Bailey, William C., Lindberg, Sarah , Dransfield, Mark T. , Han, MeiLan King , Criner, Gerard J. , Martínez, Fernando J.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | June 25, 2009 | Volume: 180 | Issue: 6 | Pages: 499-505

10.1164/rccm.200903-0488oc | PMID 19556517 Get It

Abstract Rationale Debate exists about the immunogenicity and protective efficacy of antibodies produced by the 23-valent pneumococcal polysaccharide vaccine (PPSV23) in chronic obstructive pulmonary disease (COPD). The 7-valent diphtheria-conjugated pneumococcal polysaccharide vaccine (PCV7) induces a more robust immune response than PPSV23 in healthy elderly adults. Objectives We hypothesized that serotype-specific IgG antibody concentration and functional antibody activity would be superior after PCV7 vaccination compared with PPSV23 in moderate to severe COPD. We also posited that older age and prior PPSV23 vaccination would be associated with reduced vaccine responsiveness. Methods One hundred twenty patients with COPD were randomized to PPSV23 (63 subjects) or PCV7 (57 subjects). IgG concentrations were determined by ELISA; functional antibody activity was assayed with a standardized opsonophagocytosis assay and reported as an opsonization killing index (OPK). Increases in serotype-specific IgG and OPK at 1 month post vaccination were compared within and between vaccine groups. Measurements and Main Results Both vaccines were well tolerated. Within each study group, postvaccination IgG and OPK were higher than baseline (P < 0.01) for all serotypes. Adjusted for baseline levels, postvaccination IgG was higher in the PCV7 group than the PPSV23 group for all seven serotypes, reaching statistical significance for five (P < 0.05). PCV7 resulted in a higher OPK for six of seven serotypes (statistically greater for four) compared with PPSV23. In multivariate analyses, younger age, vaccine naivety, and receipt of PCV7 were associated with increased OPK responses. Conclusions PCV7 induces a superior immune response at 1 month post vaccination compared with PPSV23 in COPD. Older age and prior PPSV23 reduce vaccine responsiveness. Clinical trial registered with www.clinicaltrials.gov (NCT00457977).
P1‐106: Brain changes in 676 ADNI subjects: summary of 10 studies using tensor based‐morphometry and automated hippocampal mapping
Thompson, Paul , Hua, Xue, Morra, Jonathan H., Apostolova, Liana G. , Lee, Suh , Avedissian, Christina, Madsen, Sarah K., Green, Amity E., Toga, Arthur W. , Shaw, Leslie M. , Trojanowski, John Q. , Weiner, Michael W. , Leow, Alex , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | June 25, 2009 | Volume: 5 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2009.04.111 Get It

IC‐P‐079: Brain changes in 676 ADNI subjects: Summary of 10 studies using tensor based morphometry and automated hippocampal mapping
Hua, Xue , Morra, Jonathan H., Apostolova, Liana G. , Lee, Suh , Avedissian, Christina, Madsen, Sarah K., Green, Amity E., Shaw, Leslie M. , Trojanowski, John Q. , Weiner, Michael W. , Thompson, Paul M. , Leow, Alex , Toga, Arthur W. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | June 25, 2009 | Volume: 5 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2009.05.633 Get It

Reliability Exercise for the Polymyalgia Rheumatica Classification Criteria Study: The Oranjewoud Ultrasound Substudy
Scheel, Alexander , Matteson, Eric L. , Bruyn, George A. W. , Werner, Carola, Schmidt, Wolfgang , Dasgupta, Bhaskar , Ohrndorf, Sarah

Mayo Clinic

International Journal of Rheumatology | June 15, 2009 | Volume: 2009 | Issue: No issue available | Pages: 1-5

10.1155/2009/738931 | PMID 20130800 Get It

Objective. A study supported by the EULAR and the ACR being conducted to establish classification criteria for polymyalgia rheumatica (PMR) will include ultrasound examination of the shoulders and hips. Ultrasound (US) depicts glenohumeral joint effusion, biceps tenosynovitis, subdeltoid bursitis, hip joint synovitis, and trochanteric bursitis in PMR. These findings may aid in distinguishing PMR from other diseases. The purpose of this study was to assess standards and US interreader agreement of participants in the PMR classification criteria study.Methods. Sixteen physicians in four groups examined shoulders and hips of 4 patients and 4 healthy adults with ultrasound. Overall agreement and interobserver agreement were calculated.Results. The overall agreement (OA) between groups was 87%. The OA for healthy shoulders was 88.8%, for healthy hips 100%, for shoulders with pathology 85.2%, and 74.3% for hips with pathology, respectively.Conclusion. There was a high degree of agreement found for the examination of healthy shoulders and pathologic hips. Agreement was moderate for pathologic shoulders and perfect for healthy hips. US of shoulder and hips performed by different examiners is a reliable and feasible tool for assessment of PMR related disease pathology and can be incorporated into a classification criteria study.
Romiplostim: A novel thrombopoiesis-stimulating agent
Burzynski, J.A., Perreault, Sarah

Mayo Clinic

American Journal of Health-System Pharmacy | April 22, 2009 | Volume: 66 | Issue: 9 | Pages: 817-824

10.2146/ajhp080524 | PMID 19386944 Get It

Acute Pancreatitis in Primary Hyperparathyroidism: A Population-Based Study
Khoo, Teck Kim, Vege, Santhi Swaroop , Abu-Lebdeh, Haitham S., Ryu, Euijung , Nadeem, Sarah , Wermers, Robert A.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | March 24, 2009 | Volume: 94 | Issue: 6 | Pages: 2115-2118

10.1210/jc.2008-1965 | PMID 19318456 Get It

Abstract Context: The association between acute pancreatitis and primary hyperparathyroidism (PHPT) is controversial. Objective: The aim of the study was to address the incidence and disease characteristics of acute pancreatitis in PHPT from a large inception cohort of community residents. Design and Setting: Patients with acute pancreatitis were identified in an Olmsted County, Minnesota, cohort of PHPT subjects diagnosed from 1965–2001 and compared to matched control subjects. Main Outcome Measures: The estimated rate of developing acute pancreatitis was calculated by person-years method. Cox models assessed the effect of PHPT disease status on the development of acute pancreatitis. Results: Of 684 patients with PHPT, 10 patients (1.5%) developed acute pancreatitis, compared to 32 of 1364 control patients (2.3%). The estimated rate of development of acute pancreatitis in PHPT was 114 per 100,000 person-years, compared to 140 per 100,000 person-years in control subjects (P = 0.56). The estimated hazard ratio of acute pancreatitis for PHPT relative to the control subjects was 0.84 (P = 0.89). The majority of subjects with PHPT and acute pancreatitis were women (n = 7), and the mean age was 70.6 yr at the time of acute pancreatitis. PHPT was present an average of 137 months before the development of acute pancreatitis, and contributing causes for acute pancreatitis were in identified in four patients. Maximal serum calcium levels in PHPT were not significantly associated with the development of acute pancreatitis. Conclusions: Acute pancreatitis was not increased in community patients with PHPT, and therefore, there does not appear to be a causal relationship between PHPT and acute pancreatitis.
Dopamine Transporter Genetic Variants and Pesticides in Parkinson’s Disease
Ritz, Beate , Manthripragada, Angelika D., Costello, Sadie , Lincoln, Sarah, Farrer, Matthew J. , Cockburn, Myles , Bronstein, Jeff M.

Mayo Clinic

Environmental Health Perspectives | February 21, 2009 | Volume: 117 | Issue: 6 | Pages: 964-969

10.1289/ehp.0800277 | PMID 19590691 Get It

Abstract Background Research suggests that independent and joint effects of genetic variability in the dopamine transporter (DAT) locus and pesticides may influence Parkinson’s disease (PD) risk. Materials Methods: In 324 incident PD patients and 334 population controls from our rural California case–control study, we genotyped rs2652510, rs2550956 (for the DAT 5′ clades), and the 3′ variable number of tandem repeats (VNTR). Using geographic information system methods, we determined residential exposure to agricultural maneb and paraquat applications. We also collected occupational pesticide use data. Employing logistic regression, we calculated odds ratios (ORs) for clade diplotypes, VNTR genotype, and number of susceptibility (A clade and 9-repeat) alleles and assessed susceptibility allele–pesticide interactions. Results PD risk was increased separately in DAT A clade diplotype carriers [AA vs. BB: OR = 1.66; 95% confidence interval (CI), 1.08–2.57] and 3′ VNTR 9/9 carriers (9/9 vs. 10/10: OR = 1.8; 95% CI, 0.96–3.57), and our data suggest a gene dosing effect. Importantly, high exposure to paraquat and maneb in carriers of one susceptibility allele increased PD risk 3-fold (OR = 2.99; 95% CI, 0.88–10.2), and in carriers of two or more alleles more than 4-fold (OR = 4.53; 95% CI, 1.70–12.1). We obtained similar results for occupational pesticide measures. Discussion Using two independent pesticide measures, we a) replicated previously reported gene–environment interactions between DAT genetic variants and occupational pesticide exposure in men and b) overcame previous limitations of nonspecific pesticide measures and potential recall bias by employing state records and computer models to estimate residential pesticide exposure. Conclusion Our results suggest that DAT genetic variability and pesticide exposure interact to increase PD risk.
Follicular Lymphoma in the United States: First Report of the National LymphoCare Study
Friedberg, Jonathan W. , Cerhan, James R. , Flowers, Christopher R. , Dillon, Hildy, Rogers, Eric S., Hainsworth, John D. , Wong, Elaine K., Zelenetz, Andrew D. , Link, Brian K. , Taylor, Michael D. , Farber, Charles Michael , Vose, Julie M. , Cerhan, James R , Link, Brian K , Zelenetz, Andrew D

Mayo Clinic

Journal of Clinical Oncology | February 9, 2009 | Volume: 27 | Issue: 8 | Pages: 1202-1208

10.1200/jco.2008.18.1495 | PMID 19204203 Get It

Purpose Optimal therapy of follicular lymphoma (FL) is not defined. We analyzed a large prospective cohort study to identify current demographics and patterns of care of FL in the United States. Patients and Methods The National LymphoCare Study is a multicenter, longitudinal, observational study designed to collect information on treatment regimens and outcomes for patients with newly diagnosed FL in the United States. Patients were enrolled between 2004 and 2007. There is no study-specific prescribed treatment regimen or intervention. Results Two thousand seven hundred twenty-eight subjects were enrolled at 265 sites, including the 80% of patients enrolled from nonacademic sites. Using the Follicular Lymphoma International Prognostic Index (FLIPI), three distinct groups independent of histologic grade could be defined. Initial therapeutic strategy was: observation, 17.7%; rituximab monotherapy, 13.9%; clinical trial 6.1%; radiation therapy, 5.6%; chemotherapy only, 3.2%; chemotherapy plus rituximab, 51.9%. Chemotherapy plus rituximab regimens were: rituximab plus cyclophosphamide, doxorubicin, vincristine, prednisone, 55.0%; rituximab plus cyclophosphamide, vincristine, and prednisone, 23.1%; rituximab plus fludarabine based, 15.5%; other, 6.4%. The choice to initiate therapy rather than observe was associated with age, FLIPI, stage, and grade (P < .01). Significant differences in treatment (P < .01) across regions of the United States were noted. Contrary to practice guidelines, treatment of stage I FL frequently omits radiation therapy. Conclusion Widely disparate therapeutic approaches are utilized for FL. Initial therapy is deferred in a small subset of patients. There is no single standard of care for the treatment of de novo FL, although antibody use is ubiquitous when therapy is initiated. These disparate approaches to the initial care of patients with FL render a heterogeneous group of patients at relapse.
Laparoscopic Radical Nephrectomy for Very Large Renal Tumors (≥10 cm): Is There a Size Limit?
Conley, Sarah P., Humphreys, Mitchell R. , Desai, Premal J., Castle, Erik P., Dueck, Amylou C. , Ferrigni, Robert G., Andrews, Paul E. , Dueck, A. C.

Mayo Clinic

Journal of Endourology | January 2, 2009 | Volume: 23 | Issue: 1 | Pages: 57-62

10.1089/end.2008.0263 | PMID 19118464 Get It